Clinical Diagnosis and Management of Gynecological Cancer
This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Special Issue Information
Dear Colleagues,
Gynecological cancers remain a major global health challenge, encompassing biologically diverse malignancies of the cervix, uterus, ovary, vulva, and vagina. According to GLOBOCAN 2024, these cancers accounted for more than 1.4 million new diagnoses and over 610,000 deaths worldwide in 2024. Their clinical management is undergoing rapid transformation, driven by advances in imaging, pathology, molecular classification, minimally invasive and robotic surgery, radiotherapy, targeted therapies, and immunotherapy. At the same time, persistent disparities in prevention, early detection, access to specialized care, and implementation of precision medicine continue to influence outcomes across regions.
This Special Issue, “Clinical Diagnosis and Management of Gynecological Cancer,” will provide an up-to-date, multidisciplinary overview of innovations across the continuum of care, ranging from screening and diagnostic pathways to surgical and systemic treatment, prognostic stratification, survivorship, and follow-up.
We welcome original research, systematic reviews, and clinically oriented studies that may improve diagnostic accuracy, personalize treatment, reduce morbidity, and ultimately enhance oncologic and patient-reported outcomes.
Dr. Sergi Fernandez-Gonzalez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gynecological cancers
- cervical cancer
- endometrial cancer
- ovarian cancer
- diagnosis
- prognosis
- survival
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

